Viewing nowDonepezil Tablets 5 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 5.22mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.

MFDS item code 202003919 · Approved 2020.05.27
Treatment of symptoms of Alzheimer-type dementia
This medication is used to treat symptoms of Alzheimer's type dementia. It helps alleviate symptoms such as memory decline and cognitive dysfunction, thereby improving the patient's ability to perform daily activities.
○ Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, maintain the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years or older with low body weight: Since adverse reactions occur frequently, careful monitoring is required. Elderly female patients with low body weight should not exceed 5 mg daily.
○ Children: There is no experience with use in children.
This medication is used in the treatment of symptoms of Alzheimer's type dementia, with Donepezil Hydrochloride Hydrate as the active ingredient. This medication should not be used in certain patients. For example, individuals with allergies to this medication or any of its components, women who are pregnant or may become pregnant, and breastfeeding women should not take this medication. In addition, as this medication contains lactose, patients with lactose intolerance or certain genetic metabolic disorders should also avoid its use. Patients with heart disease or a history of gastrointestinal diseases should take special care when using this medication. It may slow the heart rate or cause arrhythmias and may increase the risk of exacerbating peptic ulcers. Patients with asthma or obstructive pulmonary disease may also experience worsening symptoms when taking this medication, so it should be used cautiously. This medication can cause various side effects, and in rare cases, severe heart problems, gastrointestinal bleeding, liver dysfunction, and seizures may occur. Commonly reported mild side effects include nausea, vomiting, diarrhea, dizziness, and insomnia. If side effects are severe or unusual symptoms occur, immediate consultation with medical personnel is necessary. This medication has not been approved for use in other types of dementia or memory disorders other than Alzheimer's type dementia and should only be taken under the diagnosis and supervision of a specialist. During treatment, it is necessary to regularly monitor the heart condition, and particular caution is required in patients with a history of heart disease. This medication may affect driving or operation of machinery, so caution is needed, especially at the beginning of treatment or when the dosage is changed. Women who are pregnant or breastfeeding should generally not use this medication; if necessary, a decision should be made after consultation with medical personnel. Safety in pediatric patients has not been established, so it should not be used in children. This medication is metabolized in the liver, so patients with liver function abnormalities should be cautious, and potential interactions with other medications should be disclosed if the patient is taking other drugs. In cases of overdose, dangerous symptoms such as severe nausea, vomiting, hypotension, and respiratory depression may occur, necessitating immediate hospitalization, where atropine may be used as an antidote. When storing this medication, keep it in a tightly closed container to prevent exposure to air or moisture, and it is best to keep it at room temperature between 1°C and 30°C.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture exposure. Additionally, it is advisable to store it at room temperature between 1°C and 30°C.
Yellow round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 5.22mg
Tablet · Prescription medication
Ahn-Guk Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.